Practices

Cases Investigated

Beasley Allen is currently investigating the following cases involving unsafe medications. However, our attorneys would like to investigate any claims of serious injury or death that may be the result of defective medical devices or drugs.

Los Angeles jury links talc to ovarian cancer, awarding woman $417 million

August 21, 2017 - A Los Angeles jury awarded plaintiff Eva Echeverria $417 million, finding Johnson & Johnson talcum powder products responsible for her ovarian cancer. Read More


Proton Pump Inhibitor (PPI) MDL granted

August 4, 2017 - Plaintiffs are suing PPI manufacturers after developing kidney damage linked to the use of PPIs. Studies dating back to the 1990s have linked PPIs, including Nexium, Prevacid, and Prilosec,... Read More


Rare ruling in Taxotere MDL allows claims against generics

August 2, 2017 - A recent, rare ruling by the U.S. Judicial Panel on Multidistrict Litigation (JPML) allows claims against manufacturers of generic versions of Taxotere to be included in the MDL. Read More


Recent studies confirm Xarelto bleeding risks, adverse events

July 27, 2017 - There were 21,996 severe injuries reported involving anticoagulant drugs including 3,018 reported deaths, and Xarelto was the top culprit for this class of drugs. Read More


Jury hits testosterone therapy maker AbbVie with $150 million in punitive damages

July 24, 2017 - The jury found that AbbVie fraudulently marketed AndroGel by creating a condition dubbed “Low T,” presenting the product directly to men as a kind of fountain of youth. Read More


Risperdal legal troubles continue to mount

July 13, 2017 - The suit was filed by a number of child advocacy organizations on behalf of children in the Missouri foster care system who were “inappropriately provid[ed] psychotropic drugs” with... Read More


Proton Pump Inhibitor kidney injury claims MDL request renewed

July 6, 2017 - Evidence of adverse side effects, some life threatening, continues to grow, linking PPI use to Acute Kidney Injury (AKI or Acute Renal Failure) and Chronic Kidney Disease. Read More


Abilify multidistrict litigation approaches 200 lawsuits

June 30, 2017 - The FDA issued a drug safety communication about “compulsive or uncontrollable urges to gamble, binge eat, shop and have sex” based on reports from patients who had taken Abilify. Read More


Invokana clinical trial shows drug doubles risk of amputation

June 22, 2017 - Jansen reported Invokana reduced the risk of cardiovascular complications in diabetic patients, but it also doubled the number of amputations for patients taking Invokana compared to the... Read More


Talcum powder ovarian cancer trial begins in St. Louis

June 7, 2017 - The sixth talc trial against Johnson & Johnson in City of St. Louis Circuit Court started this week. Plaintiffs represent the estates of three women who died from ovarian cancer following... Read More


back to top